[go: up one dir, main page]

ZA200802935B - Use of lactobacillus for treatment of autoimmune diseases - Google Patents

Use of lactobacillus for treatment of autoimmune diseases

Info

Publication number
ZA200802935B
ZA200802935B ZA200802935A ZA200802935A ZA200802935B ZA 200802935 B ZA200802935 B ZA 200802935B ZA 200802935 A ZA200802935 A ZA 200802935A ZA 200802935 A ZA200802935 A ZA 200802935A ZA 200802935 B ZA200802935 B ZA 200802935B
Authority
ZA
South Africa
Prior art keywords
lactobacillus
treatment
autoimmune diseases
autoimmune
diseases
Prior art date
Application number
ZA200802935A
Inventor
Alenfall Jan
Berggren Anna
Rask Carola
Wold Agnes
Aghaibeik-Lavasani Shahram
Original Assignee
Brobi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brobi Ab filed Critical Brobi Ab
Publication of ZA200802935B publication Critical patent/ZA200802935B/en

Links

ZA200802935A 2005-10-06 2006-10-06 Use of lactobacillus for treatment of autoimmune diseases ZA200802935B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0502209 2005-10-06

Publications (1)

Publication Number Publication Date
ZA200802935B true ZA200802935B (en) 2009-11-25

Family

ID=40189135

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA200802935A ZA200802935B (en) 2005-10-06 2006-10-06 Use of lactobacillus for treatment of autoimmune diseases
ZA200802934A ZA200802934B (en) 2005-10-06 2006-10-06 Use of lactobacillus for treatment of virus infections

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200802934A ZA200802934B (en) 2005-10-06 2006-10-06 Use of lactobacillus for treatment of virus infections

Country Status (2)

Country Link
CN (2) CN101384269B (en)
ZA (2) ZA200802935B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101543513B (en) * 2009-05-11 2015-02-18 大连三仪动物药品有限公司 Method for producing medicine by conjugating probiotics and viruses
CN103436461B (en) * 2010-12-08 2015-03-11 益擎生技股份有限公司 Novel Lactic Acid Bacteria Strains and Their Use for Modulating Immune Responses
TWI463986B (en) * 2012-08-29 2014-12-11 Univ China Medical New use of lactobacillus plantarum cmu995 strain
EP3222282A1 (en) * 2016-03-21 2017-09-27 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of psoriasis
US11166993B2 (en) * 2017-01-12 2021-11-09 Probi Ab Methods for celiac disease using lactobacillus strains
KR102770563B1 (en) * 2018-06-18 2025-02-21 프로비 에이비 Lactobacillus plantarum composition and use thereof
KR20210024014A (en) * 2018-06-18 2021-03-04 프로비 에이비 Probiotic composition and use thereof
WO2020001747A1 (en) * 2018-06-26 2020-01-02 Symrise Ag Lactobacillus plantarum for skin care
AU2019365399A1 (en) * 2018-10-24 2021-04-22 Novozymes A/S Probiotic supplement for metabolic health comprising lactobacillus
EP3896151A4 (en) * 2018-12-12 2022-06-29 Synbio Tech Inc. Use of lactobacillus plantarum twk10 in preparation of composition for resistance to post-exercise inflammation or for reducing body fat
CN113122473B (en) * 2021-04-10 2022-08-02 江南大学 Lactobacillus BB1 enhancing memory ability and its application
CN114317343A (en) * 2021-12-28 2022-04-12 杭州普元生物技术有限公司 Lactobacillus plantarum and application thereof in preventing and/or treating central nervous system diseases
CN114085798B (en) * 2021-12-28 2023-10-31 杭州普元生物技术有限公司 Lactobacillus plantarum and application thereof in preventing and/or treating diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0003100D0 (en) * 2000-09-01 2000-09-01 Probi Ab New strains
GB0027761D0 (en) * 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
AU2003247193A1 (en) * 2003-07-23 2005-02-04 M.D.Lab Corp. Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus

Also Published As

Publication number Publication date
ZA200802934B (en) 2009-09-30
CN101384269B (en) 2012-11-14
CN101384269A (en) 2009-03-11
CN101325960B (en) 2012-05-30
CN101325960A (en) 2008-12-17

Similar Documents

Publication Publication Date Title
PL1951273T3 (en) Use of lactobacillus for treatment of autoimmune diseases
ZA200802935B (en) Use of lactobacillus for treatment of autoimmune diseases
GB0610867D0 (en) Treatment of pain
GB2429013C (en) Peptides for treatment and diagnosis of autoimmunedisease
IL193748A0 (en) Treatment of pain
IL185052A0 (en) Treatment of bone disorders
PL2056807T3 (en) Treatment of inflammatory diseases
EP1731113A4 (en) Medical treatment kit
IL193747A0 (en) New therapeutic combinations for the treatment of depression
PL2056842T3 (en) Modified-galactosyl ceramide for the treatment of cancerous diseases
EP1931390A4 (en) Compositions and methods for treatment of autoimmune disease
EP1968591A4 (en) Treatment of synucleinopathies
PL2380585T3 (en) Methods of treating autoimmune diseases
EP1954800A4 (en) Composition and use of phyto-percolate for treatment of disease
IL213703A (en) Compounds for the treatment of pain and other diseases
EP1928247A4 (en) Composition and use of phyto-percolate for treatment of disease
GB0610868D0 (en) Treatment of pain
EP1881987A4 (en) Purine derivatives and their use for treatment of autoimmune diseases
SI1890705T1 (en) Use of 24-nor-UDCA for the treatment of cholestatic liver diseases
EP1755635A4 (en) Treatment of inflammatory airway disease
GB0426196D0 (en) Methods of treatment
PL1709070T3 (en) Peptides for treatment of autoimmune diseases
GB0526394D0 (en) Treatment of inflammatory diseases
GB0616450D0 (en) Treatment of pain
GB0623740D0 (en) Treatment of disease